The National Pharmaceutical Pricing Authority has capped trade margins on 137 anti-cancer medicines at 30 percent of the MRP.
Read More

The National Pharmaceutical Pricing Authority has capped trade margins on 137 anti-cancer medicines at 30 percent of the MRP.
Read More